Renxi Wang
Impact in
- Immunology top 2%
- T-cell and B-cell Immunology
- Complement system in diseases
- Oncology top 5%
- Cytokine Signaling Pathways and Interactions
- Cancer Immunotherapy and Biomarkers
Papers in
- Immunology 40
- T-cell and B-cell Immunology 29
- Immune cells in cancer 3
- Complement system in diseases 3
- Genetics 18
- Inflammatory Bowel Disease 9
- Genetic Associations and Epidemiology 5
- Diabetes and associated disorders 4
- Co-authors
- Beifen Shen (69 shared papers)Gencheng Han (83 shared papers)Charles E. Egwuagu (6 shared papers)Cheng‐Rong Yu (5 shared papers)Guojiang Chen (60 shared papers)Chunmei Hou (49 shared papers)Rashid M. Mahdi (2 shared papers)Ivy M. Dambuza (3 shared papers)
- Journals
- Molecular Immunology (10 papers)Immunology (6 papers)PLoS ONE (5 papers)Clinical Immunology (5 papers)Scientific Reports (4 papers)
- Partner nations
- ChinaUnited StatesAustralia
In The Last Decade
Renxi Wang
130 papers receiving 3.6k citations
Renxi Wang's Hit Papers
Peers
Comparison fields: 5 of 85
- Immunology 852
- Oncology 309
- Ophthalmology 137
- Rheumatology 176
- Genetics 245
Countries citing papers authored by Renxi Wang
This map shows the geographic impact of Renxi Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Renxi Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Renxi Wang more than expected).
Fields of papers citing papers by Renxi Wang
This network shows the impact of papers produced by Renxi Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Renxi Wang. The network helps show where Renxi Wang may publish in the future.
Co-authors
The 25 scholars most cited alongside Renxi Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 142 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 641 | |
| 2 | 2017 | 154 | |
| 3 | 2015 | 146 | |
| 4 | 2016 | 146 | |
| 5 | 2013 | 125 | |
| 6 | 2015 | 89 | |
| 7 | 2016 | 86 | |
| 8 | 2012 | 83 | |
| 9 | 2014 | 74 | |
| 10 | 2010 | 72 | |
| 11 | 2013 | 58 | |
| 12 | 2016 | 57 | |
| 13 | 2014 | 56 | |
| 14 | 2019 | 53 | |
| 15 | 2004 | 50 | |
| 16 | 2015 | 48 | |
| 17 | 2019 | 47 | |
| 18 | 2022 | 46 | |
| 19 | 2010 | 41 | |
| 20 | 2012 | 41 |
About Renxi Wang
Renxi Wang is a scholar working on Immunology, Genetics, Rheumatology, Hematology and Neurology, having authored 142 papers that have together received 3.7k indexed citations. Recurring topics across this work include T-cell and B-cell Immunology (29 papers), Systemic Lupus Erythematosus Research (11 papers), Inflammatory Bowel Disease (9 papers), Multiple Myeloma Research and Treatments (5 papers), Genetic Associations and Epidemiology (5 papers), Diabetes and associated disorders (4 papers), Immune cells in cancer (3 papers) and Complement system in diseases (3 papers). The work is most often cited by research in Immunology (852 citations), Oncology (309 citations), Ophthalmology (137 citations), Rheumatology (176 citations) and Genetics (245 citations). Renxi Wang has collaborated with scholars based in China, United States and Australia. Frequent co-authors include Beifen Shen, Gencheng Han, Charles E. Egwuagu, Cheng‐Rong Yu, Guojiang Chen, Chunmei Hou, Rashid M. Mahdi, Ivy M. Dambuza, Paul T. Wingfield and Xiao He. Their work appears in journals such as Molecular Immunology, Immunology, PLoS ONE, Clinical Immunology and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.